NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

RecruitingN/A

Sponsor: AstraZeneca

Conditions: Lung Neoplasms

Countries: Canada

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Eligibility overview

Sex: ALL

Age: 18 Years to 130 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with lung cancer between January 1, 2018 and end of the Selection Period.
* Patient is 18 years of age or older on diagnosis date.
* Patient has at least 12 months of health insurance coverage prior to the diagnosis date.

Exclusion Criteria:

* Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
* Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
* Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
* Non-Ontario or non-Alberta resident on diagnosis date.

Locations (2)

Calgary, Alberta, Canada
Toronto, Ontario, Canada